A fatal infection due to avian influenza-A (H7N7) virus and adjustment of the preventive measures;Een fatale infectie door aviair influenza-A(H7N7)-virus en aanpassing van het preventiebeleid

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 44, 2004, Pages 2190-2194

  Kemink, S A G ^a   Fouchier, R A M ^b   Rozendaal, F W ^a   Broekman, J M ^a   Koopmans, M ^c   Osterhaus, A D M E ^b   Schneeberger, P M ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AVIAN INFLUENZA A VIRUS H7N7; CASE REPORT; CHICKEN; EPIDEMIC; FATALITY; FEVER; HEADACHE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; LUNG LAVAGE; MALAISE; MALE; NETHERLANDS; POULTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VETERINARY MEDICINE; VIRUS CULTURE;

ANIMALS; DISEASE OUTBREAKS; FATAL OUTCOME; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA IN BIRDS; MALE; MIDDLE AGED; NETHERLANDS; OCCUPATIONAL DISEASES; POULTRY; POULTRY DISEASES; VETERINARIANS; ZOONOSES;

EID: 7544221306     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79.
2. Rohm C, Zhou N, Suss J, Mackenzie J, Webster RG. Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 1996;217:508-16.
3. Senne DA, Panigrahy B, Kawaoka Y, Pearson JE, Suss J, Lipkind M, et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis 1996;40:425-37.
4. Kroes ACM, Spaan WJM, Claas ECJ. Van vogelpest tot influenza-pandemie; reden tot voorzorgen. Ned Tijdschr Geneeskd 2004;148:458-63.
5. Jong JC de, Claas ECJ, Osterhaus ADME, Webster RG, Lim WL. A pandemic warning? Nature 1997;389:554.
6. Suarez DL, Perdue ML, Cox N, Rowe T, Bender C, Huang J, et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol 1998;72:6678-88.
7. Update: influenza activity - United States and worldwide, 2002-03 season, and composition of the 2003-04 influenza vaccine. MMWR Morb Mortal Wkly Rep 2003;52:516-21.
8. Koopmans M, Wilbrink B, Conyn M, Natrop G, Nat H van der, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004;363:587-93.
9. Fouchier RAM, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004;101:1356-61.
10. Galama JMD. Vogelpest en oseltamivir; een terugblik. Ned Tijdschr Geneeskd 2003;147:1100-2.
11. Rapportage Commissie-Bot aan de ministers van VWS en LNV. Onderzoek naar de omstandigheden rond de ziekte van een dierenarts, en diens overlijden aan aviaire influenza. Den Haag: Ministerie van VWS; 2003.
12. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293:1840-2.
13. Perdue ML, Latimer JW, Crawford JM. A novel carbohydrate addition site on the hemagglutinin protein of a highly pathogenic H7 subtype avian influenza virus. Virology 1995;213:276-81.
14. Claas ECJ, Jong JC de, Beek R van, Rimmelzwaan GF, Osterhaus ADME. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 1998;16:977-8.
15. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-71.
16. Jong JC de, Beyer WEP, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME. De neuraminidaseremmers oseltamivir en zanamivir: een nieuw schild in de verdediging tegen influenza. Ned Tijdschr Geneeskd 2004;148:73-9.
17. National Institute for Clinical Excellence, London (NICE) 2003. Full guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. Technology Appraisal Guidance 2003:NR 58.
18. Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000;40:42-8.
19. Nicholson KG, Aoki FY, Osterhaus ADME, Trottier S, Carewicz O, Mercier CH, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-50.